Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial progenitor differentiation refers to the process by which endothelial progenitor cells (EPCs) develop into mature, functional endothelial cells. This process is crucial for vascular repair, neovascularization, and tissue regeneration. Key pathways involved include VEGF signaling, BMP4-mediated mesoderm induction, and ETS transcription factor regulation. Cell surface markers such as CD34, CD133, vWF, VE-cadherin, and eNOS are used to identify and characterize EPCs at various stages of differentiation.
Modulation of signaling pathways involved in endothelial progenitor cell mobilization, proliferation, and differentiation into mature endothelial cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial Progenitor Differentiation.